Real-World Efficacy and Safety of Liposomal Amphotericin B for Invasive Fungal Disease in Patients with Hematologic Malignancies: A Multicenter Retrospective Study.

Drug Des Devel Ther · 2026 · PMC13222603 · PMID 42226752

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Stratification by underlying hematologic malignancies showed variable success rates, ranging from 40.0% in lymphoma to 86.7% in ALL, with AML and MDS demonstrating intermediate efficacy (73.5% and 64.7%, respectively), although between-group differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.